No abstract available
Keywords:
Atherothrombosis; Low-dose anticoagulation; Peripheral artery disease (PAD); VOYAGER trial.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Blood Coagulation / drug effects*
-
Clinical Trials as Topic
-
Factor Xa Inhibitors / administration & dosage*
-
Factor Xa Inhibitors / adverse effects
-
Fibrinolytic Agents / administration & dosage*
-
Fibrinolytic Agents / adverse effects
-
Hemorrhage / chemically induced
-
Humans
-
Peripheral Arterial Disease / blood
-
Peripheral Arterial Disease / diagnosis
-
Peripheral Arterial Disease / drug therapy*
-
Peripheral Arterial Disease / mortality
-
Risk Assessment
-
Risk Factors
-
Rivaroxaban / administration & dosage*
-
Rivaroxaban / adverse effects
-
Treatment Outcome
Substances
-
Factor Xa Inhibitors
-
Fibrinolytic Agents
-
Rivaroxaban